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Understanding the regulation of human
gene expression requires knowledge of the
‘‘second genetic code,’’ which consists of
the binding specificities of transcription
factors (TFs) and the combinatorial code
by which TF binding sites are assembled
to form tissue-specific enhancer elements.
Using a novel high-throughput method, we
determined the DNA binding specificities
of GLIs 1–3, Tcf4, and c-Ets1, which medi-
ate transcriptional responses to the Hedge-
hog (Hh), Wnt, and Ras/MAPK signaling
pathways. To identify mammalian enhancer
elements regulated by these pathways on
a genomic scale, we developed a computa-
tional tool, enhancer element locator (EEL).
We show that EEL can be used to identify
Hh and Wnt target genes and to predict
activated TFs based on changes in gene
expression. Predictions validated in trans-
genic mouse embryos revealed the pres-
ence of multiple tissue-specific enhancers
in mouse c-Myc and N-Myc genes, which
has implications for organ-specific growth
control and tumor-type specificity of onco-
genes.
INTRODUCTION
Identifying mutations responsible for developmental defects
and human diseases has made a major contribution to our
understanding of biological processes. However, in part be-cause protein-coding regions of genes present larger targets
for mutagenesis than TF binding sequences, many genetic
analyses are biased toward detecting mutations that affect
the activity of proteins rather than the function of elements
that regulate gene expression. Therefore, processes that de-
pend on precise transcriptional control, such as regulation of
cell proliferation, are presently relatively poorly understood.
Cases where growth appears to be controlled in a tissue-
specific manner have proven particularly resistant to genetic
dissection. Open questions related to such tissue-specific
growth control include regulation of organ size (Conlon and
Raff, 1999), the tissue specificity of growth-factor signals,
and the tumor-type selectivity of oncogenes.
It is well established that cell proliferation can be induced
by oncogenic or growth-factor-activated TFs, such as GLI2
or Tcf4, whose activities are regulated by the Hh andWnt sig-
naling pathways, respectively (Bienz and Clevers, 2000; Tai-
pale and Beachy, 2001). However, the conserved enhancer
or promoter elements through which these TFs regulate the
expression of cell-cycle regulatory genes in vivo are generally
not known.
Several reasons have made the identification of such ele-
ments difficult. First, the information about TF binding spec-
ificity is often incomplete, in part due to the difficulty of
measuring affinities of large numbers of TFs to DNA using
methods such as electrophoretic mobility shift assay (EMSA;
Fried and Crothers, 1981) or SELEX (Roulet et al., 2002).
Second, the identification of mammalian enhancer elements
by computational or experimental methods has proven to be
challenging.
Genome-wide in silico analyses of conserved mammalian
regulatory sequences have largely concentrated on untrans-
lated regions of mRNAs (Xie et al., 2005) or promoter ele-
ments (Suzuki et al., 2004; Xie et al., 2005), 1–3 kb se-
quences located immediately upstream of the transcription
start site. However, the enhancer elements that control pro-
moter activity are often located quite far from the transcrip-
tion start site (> > 10 kb). A single promoter can be regulated
by one or many relatively short (1 kb) enhancer modules,Cell 124, 47–59, January 13, 2006 ª2006 Elsevier Inc. 47
which are activated by binding of multiple TFs. If multiple en-
hancer modules regulate one promoter, the corresponding
gene is expressed in all tissues where one or more of the en-
hancer elements are active, and thus the expression pattern
of a gene reflects the combined activity of all the enhancer
modules that are capable of activating its transcription (re-
viewed in Michelson, 2002).
Whereas in silico methods efficiently identify enhancer
modules in Drosophila (Michelson, 2002), mammalian en-
hancer prediction on a genomic scale has not been possible
due to the higher complexity ofmammalian genomes. Exper-
imentally, individual mammalian enhancer elements regulat-
ing a particular gene can be identified by locating genomic
sequences that direct tissue-specific expression of marker
genes in transgenic embryos (Spitz et al., 2003), followed
by progressive deletion of these sequences, often aided by
analysis of conservation of the sequences in multiple spe-
cies. However, this is a difficult and time-consuming process
that is not easily adaptable for genome-wide studies.
In this work, we have developed a high-throughput
method for TF binding specificity analysis and a novel com-
putational tool, EEL, for the identification of mammalian en-
hancer elements, which allows genome-wide analysis of hu-
man distal enhancer elements. We have further applied
these enabling technologies to the identification of target
genes of developmental signaling pathways and to the anal-
ysis of regulation of two central growth-regulatory genes in
mammals, c-Myc and N-Myc.
RESULTS
Development of High-Throughput Method for
Determination of TF Binding Specificities
To allow rapid and accurate analysis of TF binding specific-
ities, we developed a high-throughput method that directly
determines the relative affinities of a TF to different DNA se-
quences. For this purpose, we fused the DNA binding do-
mains of all GLI family TFs (GLI1, 2, and 3 and the Drosophila
GLI ortholog Ci) to Renilla reniformis luciferase. We next ex-
pressed the GLI-Renilla fusion proteins, incubated themwith
biotinylated double-stranded oligonucleotide containing the
sequence with the highest affinity to GLIs (consensus se-
quence), and measured the luciferase activity captured on
a streptavidin plate. Competing this reaction with different
unlabeled oligonucleotides (Figure 1A) allowed determina-
tion of the relative affinity of the GLI proteins to all possible
single-base substitutions (Liu and Clarke, 2002) to the con-
sensus sequence (Figures 1B and D). The affinities from the
binding assay were consistent with results from an EMSA
assay (Figure 1C).
We next made similar binding-affinity tables for Tcf4 and
c-Ets1 (Figure 1D; see also Table S1 in the Supplemental
Data available with this article online), which are regulated
by Wnt and Ras/MAPK signaling pathways, respectively.
Relative affinities obtained using our assay were consistent
with the crystal structure of GLI1 bound to its consensus se-
quence (Pavletich and Pabo, 1993), published biologically
relevant binding sites of GLI and Tcf/LEF TF families, and the48 Cell 124, 47–59, January 13, 2006 ª2006 Elsevier Inc.known semiquantitative DNA binding preference of c-Ets1
(see Table S1).
Enhancer Element Locator
To identify conserved enhancer elements regulated by GLI
and Tcf4, we developed a novel local (Smith and Waterman,
1981) alignment algorithm, enhancer element locator (EEL),
that aligns the sequence (i.e., order) of TF binding sites found
on two orthologous DNA sequences from two species (Fig-
ure 2A). The DNA sequence is not directly used in the align-
ment because only a fraction of all nucleotides in mammalian
genomes code for high-affinity TF binding sites and because
multiple DNA sequences can code for the same site. Our ap-
proach is thus conceptually similar to aligning peptide se-
quences instead of the corresponding DNA sequence and
should similarly result in increased specificity and sensitivity.
The scoring scheme of EEL takes into account TF binding-
site clustering, affinity, and conservation (Figure 2A; see
Supplemental Data for details). A negative score is given
for increased distance between adjacent conserved TF bind-
ing sites, and a positive score is given for conserved TF
binding sites on the basis of their total relative affinities. As-
sessing true affinities of TF binding sites to DNA is difficult
because binding of TFs to DNA is often cooperative, and se-
quences that by themselves bind only weakly to a particular
TF can be occupied and biologically relevant in vivo due to
increased affinity caused by secondary interactions between
TFs or between the TF and other proteins. Because these
secondary interactions cannot be modeled using current
data, we included correction factors that describe the max-
imum loss of free energy caused by loss of secondary inter-
actions due to an insertion of sequence between the adja-
cent TF binding sites. The correction is based on the
energy required for twisting and/or compressing the two
DNAs of unequal length into structures that would allow sim-
ilar 3D positions for both pairs of TFs.
An important feature of EEL is that all TFs loaded to the
program are treated equally, allowing simultaneous identifi-
cation of a large number of conserved sites for different
TFs. Subsequently, the alignments containing specific TF
binding sites can be selected from this general analysis.
We first tested EEL by determining whether it could iden-
tify enhancer elements in the best characterized gene that is
regulated by multiple enhancers, Drosophila even-skipped
(eve) (Berman et al., 2002; Small et al., 1996). Analyzing
eve genomic sequences of D. melanogaster and D. pseu-
doobscura with EEL using published binding-affinity matri-
ces (Berman et al., 2002) for the five known TFs that regulate
eve, we could identify all four known enhancer elements that
control the segmental expression of eve in Drosophila em-
bryos (Figures 2B and 2C).
Genome-wide Prediction of Mammalian Enhancer
Elements
To adapt EEL for the more complex vertebrate genomes, we
optimized the parameters of the penalty function by a greedy
hill-climbing procedure (see Supplemental Data) using 107
binding profiles obtained by combining our own analyses
Figure 1. A High-Throughput Method for Measurement of TF Binding Specificity
(A) GLI2-zinc-finger Renilla luciferase fusion protein was incubated with competitor oligonucleotides indicated in the absence or presence of a biotinylated
oligonucleotide containing theGLI consensus binding sequence. BoundGLI2 wasmeasured asRenilla luciferase activity. Error bars represent one standard
error (n = 8).
(B) Complete binding profile of GLI2. Bases 1–10 and 14, which contact the GLI protein, were analyzed (see Experimental Procedures).
(C) Verification of the results of the DNA binding assay by EMSA.
(D) Binding profiles of GLIs 1–3, Ci, Tcf4, and c-Ets1 described by differentially sized letters. The height of a letter at a particular position is directly propor-
tional to the effect of that nucleotide substitution on the binding affinity (relative to consensus) of the indicated TF.with high-quality TF binding profiles available in the literature
and in the JASPAR2 database (see Tables S1 and S2 and
Sandelin et al., 2004). Optimization resulted in relatively large
penalties for differences in distance and angle, consistent
with the initial hypothesis on the importance of the second-
ary interactions for TF binding.
We next tested EEL on a classic example of a distal en-
hancer in mammals, the 20 kb enhancer of MyoD (Gold-
hamer et al., 1995). The highest scoring cis-module resulting
from the alignment of 50 kb mouse and human MyoD se-
quences was located to another gene 30 of MyoD, the sec-
ond was the 20 kb distal enhancer of MyoD, and the third
was in the MyoD coding region (Figure 2D). These results in-
dicate that EEL can also identify mammalian distal en-
hancers.
To predict enhancers genome-wide, we performed an
EEL alignment of all 20,173 homologous human-mouse
gene pairs (17,429 human genes with their 20,173 mouse
orthologs from the ENSEMBL database). The aligned se-
quences included the genomic sequences from first to lastexon and 100 kb of flanking sequence in both directions.
The results were placed in a relational database containing
information about the aligned regions, predicted enhancer
modules, and conserved TF binding sites (Figure 3A). This
database was subsequently used to determine the fre-
quency of conserved binding sites for all of the 107 TFs
used in the alignment (Figure 3B, top panel).
Identification of Activated TFs Based on Changes
in Gene Expression
To test whether the genome-wide data could be used to de-
termine which TFs are activated in an experiment based on
gene-expression data, we also determined frequencies of
all 107 TF sites in predicted enhancer elements of 13 genes
whose expression is induced in the colon of mice after inac-
tivation of the adenomatous polyposis coli (APC) tumor sup-
pressor (Sansom et al., 2004). The second most overrepre-
sented TF site in the flanking regions of these genes was Tcf4
(Figure 3B), which is known to be activated by the loss ofCell 124, 47–59, January 13, 2006 ª2006 Elsevier Inc. 49
Figure 2. EEL, a Novel Local Alignment Tool that Aligns Two TF Binding-Site Sequences
(A) EEL scoring function. Top: schematic representation of two TFs (blue and red ovals) bound to DNA of unequal length from two different species. Side
view (top left) indicates mean distance (x) and difference in distance (Dx), and front view (top right) indicates difference in angle (Df) of the two factors bound
to DNA (open circle). Position weight matrix scores for TFs were used as a proxy for binding affinity in calculation of DGT, the sum of TF affinities to sites in
both species. Bottom: the score function. See Supplemental Data for details.
(B) EEL analysis (left) using the five known TFs that regulate eve (Hunchback, Caudal, Knirps, Bicoid, and Kruppel) identifies all four enhancers driving striped
expression ofDrosophila eve (right). Blue diagonal lines indicate aligned regions, and black lines on the x and y axes represent the conserved TF binding sites
that constitute the cis-modules (CM). Number after the CM indicates its rank based on its EEL score.
(C) Text display of EEL alignment of part of the eve Stripe 3/7 enhancer (CM1 from [B]). D. pseudoobscura and D. melanogaster sequences are on top and
bottom lines, respectively. EEL aligns the DNA sequences between the conserved TF sites for clarity; the DNA alignment does not contribute to the EEL
score. Yellow boxes indicate conserved binding sites of Hunchback (Hb) or Knirps (Kni), which regulate this cis-module (Small et al., 1996).
(D) A distal 20 kb enhancer element in the mouse and human MyoD genes is identified by EEL analysis.APC (Bienz and Clevers, 2000). With an even higher confi-
dence value, a pair of Tcf4 sites were identified as the
most overrepresented pair of the same binding sites in indi-
vidual enhancer elements of the APC target genes (Fig-
ure 3B; p = 0.00083; 92% confidence after correction for
multiple hypothesis testing). We also performed similar ana-
lyses for all possible TF site pairs, identifying Tcf4+Tcf4 as the
second most overrepresented pair (Figure 3C; Table S2).
These results validate the biological relevance of our TF bind-
ing-specificity assay and indicate that genome-wide EEL re-50 Cell 124, 47–59, January 13, 2006 ª2006 Elsevier Inc.sults can be used to identify activated TFs on the basis of ex-
pression-profiling data.
In Silico Identification of Hh/GLI Target Genes
To further validate EEL through unbiased genome-wide
analysis of its predictions and to test the feasibility of identi-
fying conserved target genes of developmental signaling
pathways in silico, we performed pairwise genome-wide
EEL alignments of human genes to orthologous rat, chicken,
and pufferfish genes (Figure 4A). Similarly to in the human-to-
mouse analysis, all the 107 TF sites were included in these
alignments.
Since the presence of two binding sites for the same factor
resulted in the highest confidence values in the analysis de-
scribed above (Figure 3B), we selected elements that con-
Figure 3. Genome-wide EEL Analysis of Enhancer Elements
in Mammals
(A) Schematic description of the alignment procedure.
(B) Analysis of overrepresentation of TF binding sites in genes regulated
by the APC tumor suppressor. The 107 vertical colored lines in the left
panels represent the different TFs used in the analysis. The colors repre-
sent values on a color scale (corresponding right panels) indicating site
frequency (top two panels) or overrepresentation of the TFs (log10(p))
in APC target genes (bottom two panels).
(C) Overrepresentation of pairs of any two TF binding sites in the same
predicted cis-module in the APC target genes. The two pairs of TFs hav-
ing the lowest p values are also indicated. See Table S2 for identity of the
107 TFs.tained a minimum of two GLI binding sites of combined rel-
ative affinity score of 25 or more, were shorter than 2000 bp,
and had an EEL alignment score higher than 500. As few
clusters of multiple conserved GLI sites are found in the
genome, this high an EEL score requires the presence of
multiple conserved sites for other TFs in the predicted
element.
Using mouse-to-human alignment alone, a total of 42 ele-
ments met these criteria. Two out of three (p = 8.8  105)
in vivo-validated direct GLI targets (Table S3; Figure 4B, red
typeface; see Supplemental Data for standards of evidence)
contained such an element in their aligned regions. These
were the two known marker genes for GLI activity, GLI1
and PTCH1 (Ingham and McMahon, 2001; Taipale and
Beachy, 2001), which are induced by Hh ligands in all tissues
examined. The predicted enhancer of PTCH1 was the same
one that was identified previously (Agren et al., 2004), con-
taining one high-affinity and one lower-affinity GLI site, an ar-
rangement which is potentially important in graded re-
sponses to Hh. Of the 42 elements, 7 were also conserved
in the human-to-rat alignment (Figure 4B, blue and red dia-
monds). Only one element with two GLI sites was also con-
served in chicken (Figure 4B, red diamond), and none was
conserved in pufferfish.
To further validate the predictions, we analyzed the ex-
pression pattern of a subset of the predicted genes and en-
hancers. During early embryogenesis, Sonic hedgehog (Shh)
expressed by the notochord and floor plate (see Figure 4C) is
important for the patterning of the ventral neural tube and the
sclerotome and epaxial myotome of the somites (Chiang
et al., 1996; Wijgerde et al., 2002). Shh is also characteristi-
cally expressed in the endoderm (Figure 4C) and posterior
margin of the developing limb buds and at later stages in
whisker (E12.5) and hair (E14.5) follicles. Target genes of
Shh are expressed in some cases in most or all responding
cells (e.g., PTCH1; Figure 4D) but more commonly are re-
stricted to particular Shh-responsive tissues at specific de-
velopmental stages (e.g., Tbx2 and FoxF1; Figures 4E and
4F), consistent with the ability of Hh proteins to induce di-
verse cellular responses during development (for review,
see Ingham and McMahon, 2001).
We next analyzed the expression pattern of predicted Shh
target genes that were located close to 16 conserved en-
hancer elements having high GLI affinity scores (see Table
S3 for details). Ten genes were expressed at the analyzed
stage in a relatively restricted pattern. Five expression pat-
terns were consistent with regulation by Shh: Three corre-
sponded to previously known Shh targets (PTCH1, Tbx2,
and FoxF1) and two to genes whose regulation by Shh has
not been reported. Of these, GPC3 was expressed in the
sclerotome of the somites (Figure 4H) and SOX13 in the ven-
tral neural tube (Figure 4G; see Table S9 for overview).
To test whether the predicted sequences functioned as
enhancer elements, we assessed their ability to direct
LacZ marker-gene expression to specific tissues of trans-
genic mouse embryos. Three of four highest scoring (see
Table S8) predicted Shh-regulated enhancer elements ana-
lyzed directed LacZ expression into tissues that are specifiedCell 124, 47–59, January 13, 2006 ª2006 Elsevier Inc. 51
Figure 4. Identification of Hh Target
Genes
(A) Description of the pairwise genome-wide
alignments (star alignment) performed.
(B) Plot of predicted GLI-regulated enhancer ele-
ments. Coloring of diamonds indicates conserva-
tion in alignments of human to mouse (green), rat
(blue), chicken (red), and pufferfish (gray). Large
diamonds represent genes that have been re-
ported to be induced by Hh; direct targets vali-
dated in vivo are in red typeface. Genes indicated
with an asterisk are analyzed in (D)–(K).
(C–H) Expression pattern of Shh (C) and known
(PTCH1 [D], TBX2 [E], and FOXF1 [F]) and pre-
dicted (SOX13 [G] and GPC3 [H]) Hh target
genes. Black and red arrowheads indicate nasal
process and gut, respectively, and arrows indi-
cate ventral neural tube (red), ventral otic vesicle
(black), and sclerotome (white). All embryos are
analyzed by in situ hybridization at E9.5, except
for SOX13 (E11.5).
(I–K) Analysis of predicted Hh-regulated en-
hancer elements in E12.5 mouse embryos.
PRDM10 enhancer drives expression in ventral
neural tube ([I], arrowhead). NM_018271 en-
hancer (J) directs LacZ expression into whisker
follicles (inset), ventral neural tube (arrowhead),
and posterior aspect of limbs (asterisk). GPC3
enhancer (K) directs LacZ expression into sclero-
tome-derived tissue of the vertebral cartilage pri-
mordia (inset) at E12.5. Sectioning plane is also
indicated.by Shh. Enhancer from PRDM10 drove expression in ventral
neural tube (6 of 6 LacZ-positive embryos; Figure 4I);
NM_018271 drove expression in ventral neural tube, whisker
follicles, and posterior aspect of limb buds (5 of 6 embryos;
Figure 4J); and enhancer from glypican3 (GPC3) specifically
directed marker-gene expression into sclerotomally derived
tissues (vertebral cartilage primordia, 6 of 6 embryos; Fig-52 Cell 124, 47–59, January 13, 2006 ª2006 Elsevier Inc.ure 4K; at E12.5, GPC3 is expressed in a similar pattern [Pel-
legrini et al., 1998]). Although all of the enhancer elements
tested (Figures 4I–4K) had two GLI binding sites with similar
affinity (Table S3), the specific tissues into which they di-
rected expression were different, indicating that the other
TF binding sites in the enhancer modules critically restrict ex-
pression to particular tissues.
Figure 5. Identification of Wnt Target Genes
(A) Plot of predicted Tcf4-regulated enhancer elements. Coloring of diamonds indicates conservation in alignments of human to mouse (green), rat (blue),
chicken (red), and pufferfish (gray). Large diamonds represent genes that have been reported to be induced byWnt; direct targets validated in vivo are in red
typeface. Expression of genes indicated with an asterisk is analyzed in (B)–(I).
(B–I) Expression pattern ofWnt5A (B) and one known (AXIN2 [light stain], [C]) and five predicted Tcf4 target genes. Tail bud (red arrowhead), limb buds (black
arrowheads), and AER (black arrows) are also indicated. Embryos are E9.5 (B–H) and E10.5 (I).
(J) Plot of predicted enhancer elements containing both GLI and Tcf4 sites.Identification of Wnt/Tcf4 Target Genes
Similar analysis of Tcf4-regulated genes based on the hu-
man-to-mouse alignment identified 132 predicted enhancer
elements. One of these elements was in aligned regions of
AXIN2, one of the three known direct Tcf/LEF target genes
that have been validated by enhancer analysis in vivo in
transgenic mice (Figure 5A, red typeface; Table S4). A total
of six elements (4.5%) were located close to other reported
Tcf4-inducible target genes, including LEF-1, LMX1A,
c-Met, CDX2, and c-Myc (Figure 5A; Table S4). Elements
located close to reported Tcf4 target genes were further
enriched among the predictions if only elements conserved
also in rat (8.5%; 5 of 59) or both rat and chick (14%; 2 of
14) were considered (Figure 5A).
We next assessed whether the predicted genes were ex-
pressed in a pattern consistent with Wnt regulation. At E9.5,
Wnt3, Wnt5A (Figure 5B), Wnt5B, and many Wnt target
genes (e.g., AXIN2; Figure 5C) are expressed in the tailbud, a structure whose formation depends on Wnt signals
(Huelsken et al., 2000). Wnts are also required for the forma-
tion of the apical ectodermal ridge (AER) of the developing
limbs (Barrow et al., 2003). Twelve predicted Wnt target
genes analyzed that were located close to 25 conserved en-
hancer elements with high Tcf4 affinity scores (Table S4)
were expressed at E9.5 in a specific pattern. Expression pat-
terns of five genes that had previously not been character-
ized as Wnt targets were clearly consistent with Wnt regula-
tion. Of these, four were expressed in the tail bud (Figures
5D–5G) and one in the AER (Figures 5H and 5I). Four addi-
tional genes, including a known Wnt target (LEF1), had
somewhat more general expression patterns with markedly
elevated expression in the tail (Figure S3).
It is interesting to note that several genes that are known to
be induced by Shh and/or Wnt also contained enhancer
elements having both a conserved GLI and Tcf4 sites, raising
the possibility that these genesmay be involved in integrationCell 124, 47–59, January 13, 2006 ª2006 Elsevier Inc. 53
of Hh and Wnt signals during development (Figure 5J; Table
S5).
Analysis of Regulation of c-Myc and N-Myc
Finally, we tested the practical utility of EEL in dissecting
biological problems by applying it to the analysis of organ-
specificgrowthcontrol. For thispurpose,weanalyzedwhether
the expression of a central family of growth-regulatory genes,
the Myc genes, is under the control of multiple tissue-
specific enhancer elements.
We first analyzed the predicted Tcf4-regulated enhancer
on the c-Myc gene. c-Myc is a known target of theWnt path-
way in colorectal cancer (He et al., 1998), and its expression
in vivo appears to depend on distal elements that have not
been identified (Lavenu et al., 1994). EEL predicted several
conserved enhancer elements for the c-Myc locus, two of
Figure 6. Analysis of Enhancer Elements in c-Myc
(A) EEL predicts two enhancer elements (CM3 and CM5) in human c-Myc
that contain conserved Tcf4 binding sites (circled).
(B–F) Analysis of the predicted enhancers in E12.5 mouse embryos. c-
Myc-CM3 enhancer directs LacZ expression to the ventral neural tube
([B] and [E], arrows) and to the eye ([D], arrow). c-Myc-CM5 drives expres-
sion in dorsal root ganglia ([C] and [F], arrow).54 Cell 124, 47–59, January 13, 2006 ª2006 Elsevier Inc.which (CM3 and CM5) contained conserved Tcf4 sites (Fig-
ure 6A). CM3 directed marker-gene expression into the ven-
tral aspect of the neural tube and in the eye (4 of 5 LacZ+
embryos; Figures 6B, 6D, and 6E). CM5, in turn, drove ex-
pression in dorsal root and trigeminal ganglia (7 of 8 em-
bryos; Figures 6C and 6F; compare to Schmid et al., 1989).
The Hh-GLI pathway induces the expression of N-Myc,
which encodes a protein that functions similarly to c-Myc. In-
duction of N-Myc is critical for Shh-induced cell proliferation
of cerebellar granule neuron progenitors (CGNPs; Kenney
et al., 2003; Oliver et al., 2003), and its expression depends
on distal elements that have not been identified (Charron
et al., 2002). Multiple predicted enhancer modules were
identified in the N-Myc locus (Figure 7A), two of which
(CM5 and CM7) contained GLI binding sites conserved in
human, chimpanzee, and rat. At E12.5, the predicted en-
hancer located in the second intron (CM7) drove expression
specifically in the maxillary arch derivatives, including mouth
(Figure 7B), and in the developing tooth buds (6 of 7 em-
bryos; Figure 7E). The pattern of expression in the tooth pla-
code is localized to regions where Shh is specifically ex-
pressed and acts as a mitogen (Cobourne et al., 2001) to
induce localized epithelial thickenings that invaginate to
form the tooth bud. Also, the distal +65 kb enhancer (CM5)
drove expression in a tissue-specific manner in the forebrain
(Figures 7C and 7F; thalamus and roof of neopallial cortex)
and in dorsal aspect of the neural tube (4 of 5 embryos;
Figure 7G). Although LacZ is present also in postmitotic neu-
rons, probably due to stability of the protein, the position of
the LacZ expression along the dorsoventral axis of the neural
tube is consistent with the known expression domain of
N-Myc RNA (Kenney et al., 2003). Consistent with a role of
this enhancer also in mediating growth responses to Shh,
CM5 drove expression at postnatal day 3 (PN3), specifically
in the CGNPs of the external granule cell layer of the cerebel-
lum (4 of 6 LacZ-positive mice; Figures 7D and 7H). Two ad-
ditional N-Myc-derived sequences tested that contained
a conserved GLI site (or sites), one in the coding region of
N-Myc and the other at +48.5 kb (GLI site not conserved
in chimpanzee), did not drive expression in a tissue-specific
manner at E12.5. These sequences either do not represent
enhancers or function at a different developmental stage.
These results indicate that the expression of the Myc
genes is controlled by multiple tissue-specific enhancer ele-
ments and further demonstrate the utility of EEL in identifying
distal enhancers in mammals.
DISCUSSION
Determination of TF Binding Specificities
Information about TF binding-site specificity is often incom-
plete (i.e., only the site with maximal affinity is known) or
biased by the prediction methods used (such as alignment
of multiple potential binding sites). To resolve this problem,
we developed a novel microwell-plate-based TF binding-
specificity assay. The assay has broad utility, as it can be
used for multiple classes of TFs, including zinc-finger (GLI),
high-mobility-group (Tcf4), and ETS-domain (c-Ets1) DNA
Figure 7. Analysis of Enhancer Elements in N-Myc
(A) EEL analysis identifies two GLI binding-site-containing predicted enhancer elements in human N-Myc (arrow and circle).
(B–H) At E12.5, N-Myc intronic enhancer (N-Myc-CM7) directs expression to the ventral side of the neck and in the mouth (B), specifically to the developing
tooth buds ([E], arrow). N-Myc-CM5 enhancer directs expression to the forebrain ([C] and [F]) and to the dorsal aspect of the neural tube ([G], arrows), ex-
cluding ventral neural tube (black arrowhead) and roof plate (red arrowhead). At postnatal day 3 (PN3), N-Myc-CM5 drives expression into the external gran-
ule cell layer of the cerebellum ([D] and [H], red arrow).binding proteins. Therefore, using high-throughput methods
similar to those described here, it should be feasible in the
near future to determine the binding specificities of the esti-
mated 2000 DNA binding proteins (Tupler et al., 2001) in the
human genome.
Because our method depends on prior knowledge of the
site with maximal affinity but is capable of directly determin-
ing relative affinities, it complements recently described
microarray-based high-throughput TF binding-specificity
assays (Liu et al., 2005; Mukherjee et al., 2004) that can
identify unknown consensus sequences but rely on indirect
means to estimate affinity. In particular, the established high-
throughput methods rely on computational tools to find DNA
binding-site motifs from the sequences included onmicroar-
rays. This leads to a bias toward the sequences that are in-
cluded. More importantly, using alignment-based methods,
it is very difficult to determine affinities as opposed to rank of
affinities. Because high-affinity sites can become saturated,
the concentration of TF used and the threshold for inclusion
of sequences into the alignment affects the ‘‘stringency’’ of
the obtained TF binding-specificity matrix.
Prediction of Mammalian Enhancer Elements
We report here the genome-wide prediction of mammalian
enhancer elements and assignment of all publicly available
high-quality TF binding sites to these enhancers in human,
mouse, rat, chick, and pufferfish. Whereas a large number
of studies have identified enhancer elements in Drosophila,
genome-scale methods have not previously been applied
to mammalian enhancer prediction.
In Drosophila, enhancer elements can be efficiently identi-
fied by using algorithms based on clustering of a limited
number of TF binding sites in one (Berman et al., 2002;
Markstein et al., 2002; Rajewsky et al., 2002) or multiple
(Sinha et al., 2004) species. However, clustering analysis isnot as powerful in mammals, as mammalian regulatory ele-
ments typically have a very limited number of binding sites
for any individual TF (see, for example, Agren et al., 2004;
Lickert and Kemler, 2002). For example, clustering analysis
clearly identifies the Hh-regulated element in the Ptc gene
ofDrosophila (Figure S1A), but the analysis of corresponding
human sequences results in identification of five elements
that have higher scores than that corresponding to the
known enhancer (Figure S1C). A total of 15 elements are
found using a signal-to-noise cutoff that in Drosophila would
result in the inclusion of the first incorrect module. The de-
creased clustering of human GLI sites thus decreases signal
intensity, and the larger size of the human genome increases
noise, making enhancer prediction inmammalsmore difficult
than in Drosophila (Figure S1E).
Presumably due to these difficulties, genome-scale stud-
ies in mammals have concentrated on promoters or 30 un-
translated regions (e.g., Suzuki et al., 2004; Xie et al.,
2005) or multispecies conserved sequences (MCS). The
MCS are sequences that are very well conserved in multiple
vertebrate species. Although the MCS are much more con-
served than the sequences of known enhancers and their
role in other processes (e.g., as replication origins or modu-
lators of chromatin structure) has not been carefully studied,
some of these elements clearly regulate gene expression.
However, none of the 1400 sequences conserved between
human and pufferfish (Woolfe et al., 2005) overlaps with
known Hh- or Wnt-responsive elements.
Because DNA-based alignment methods treat all nucleo-
tides as equivalent, their use for identification of enhancer
modules has important information theoretical limitations
(see Supplemental Data), and they cannot reach the sensitiv-
ity and specificity of EEL, which only analyzes the information
that is relevant for enhancer function (TF binding sites and
their relative positions). The power and specificity of EEL isCell 124, 47–59, January 13, 2006 ª2006 Elsevier Inc. 55
demonstrated by the fact that even though only between 5%
and 20% of all TF binding specificities are currently known
andwere included in our analysis, wewere able to accurately
predict mammalian enhancer elements on a genomic scale.
Despite the large gap in our knowledge of TF DNA binding
specificities, a method using EEL score also outperformed
the use of DNA-alignment-based score in identification of
known GLI target genes (Table S7). These results suggest
that alignment based on TF binding siteswill become an even
more powerful method of analysis of regulatory elements
when more information on TF binding specificities becomes
available.
In Silico Identification of Hh and Wnt Target Genes
We also applied the genome-wide data on conserved en-
hancer modules and binding sites for the identification of tar-
get genes of developmental signaling pathways. Identifica-
tion of target genes of pathways such as Hh and Wnt by
expression profiling or chromatin immunoprecipitation is
made difficult by the cell-type- and developmental-stage-
specific cellular responses to these signals. These context-
dependent responses do not affect our in silico analysis
based on conserved TF binding sites in genomic sequences.
Seven out of ten predicted enhancer elements that we
tested in vivo directed tissue-specific expression at the one
developmental stage tested (E12.5 mouse embryo). In addi-
tion, a significant fraction (3 of 6) of well-established (see Ta-
bles S3 and S4) direct targets of the Hh and Wnt pathways
were identified by EEL. Between 5% and 25% of the genes
predicted to be regulated by the Hh or Wnt pathways had
been previously reported as targets for these pathways. To
further validate the predictions, we analyzed expression of
the predicted genes in tissues that are specified or induced
byWnt (tail bud, AER) or Hh (ventral neural tube, sclerotome).
In these tissues, the Hh or Wnt signals are by definition the
most upstream modulators, and, in the genetic sense, all
genes specifically expressed in the induced tissues are direct
or indirect targets of Hh or Wnt. At the one developmental
stage analyzed, 31% and 36% of the GLI- and Tcf4-regu-
lated enhancers predicted, respectively, were located close
to genes expressed in a pattern consistent with our predic-
tions (Table S9). Prediction of GLI or Tcf4 target genes signif-
icantly enriched also novel genes whose expression patterns
were consistent with regulation by Hh or Wnt, respectively
(p < 3.4 103 and < 3.3 105 for novel and all genes, re-
spectively; see Table S9). As there are other TF binding sites
in addition to GLI and Tcf4 in the predicted enhancers, we
cannot rule out that they also direct expression indepen-
dently of Hh and/or Wnt. Thus, further validation of the pre-
dictions by targeted mutations of the TF binding sites in the
mouse genome are needed to analyze the biological conse-
quences and conclusively determine the directness of the in-
dividual predicted regulatory interactions.
Because of the cell-type-specific response to Hh andWnt,
it is not feasible to determine which genes are not regulated
by these pathways, as this would require analysis of all cell
types during all developmental stages. As not all target
genes are expected to be regulated at the developmental56 Cell 124, 47–59, January 13, 2006 ª2006 Elsevier Inc.stage analyzed here, the fraction of the predicted enhancers
that are targets of Shh or Wnt is likely to be higher than the
31%–36% estimated above. Furthermore, because the
EEL approach is general and simultaneously identifies con-
served sites for a large number of TFs, similar analyses can
be performed to identify target genes for any TF whose
DNA binding specificity is known.
Conservation of Enhancer Elements
Increasing the number of species analyzed from two to three
appeared to increase the quality of the EEL predictions
(Tables S3 and S4). However, at the same time, the total
number of predicted modules was decreased. This effect
could be partially alleviated by requiring that only one GLI
or Tcf4 site be conserved (Table S6). One factor explaining
the decrease is the cumulative effect of incorrect or missing
sequences or annotation in the present draft genomes. Thus,
improvement of the quality of genomic sequences and
development of multiple-alignment programs using several
mammalian sequences are also expected to further improve
the EEL method. However, inclusion of multiple species may
not be beneficial in all cases, as evolutionary changes in the
function or expression pattern of genes are also expected to
contribute to the decreased conservation of enhancer ele-
ments. On the other hand, EEL makes it possible to study
such regulatory evolution on a genomic scale. Furthermore,
EEL can also be applied to prediction of regulatory single-
nucleotide polymorphisms (SNPs), which are believed to
be a major factor contributing to differences in gene expres-
sion in the human population.
Organ-Specific Growth Control
Our results suggest that the expression of the Myc genes is
controlled by multiple independent tissue-specific enhancer
modules. This allows growth to be regulated specifically in
distinct tissues and organs, contributing to the understand-
ing of the hitherto poorly understood mechanisms of organ-
specific growth control.
We also find here that, instead of being regulated by a sin-
gle element that is responsive to Shh in all tissues, N-Myc
appears to be regulated by at least two distinct tissue-spe-
cific enhancer elements containing conserved GLI binding
sites. These enhancers drive expression in the tooth bud
and the external granule cell layer of the cerebellum, tissues
where Shh is known to regulate growth and induce N-Myc
expression (Cobourne et al., 2001; Kenney et al., 2003;
Oliver et al., 2003). Thus, it is likely that tissue-specific TFs re-
strict the ability of Shh to induce N-Myc to particular tissues.
Specificity of Oncogenes
Tissue-specific regulation of the Myc genes is also relevant
to the problem of tumor-type selectivity of oncogenes. De-
spite heterogeneity in genotype, all cancer cells share com-
mon phenotypic characteristics, such as unrestricted
growth (Hanahan andWeinberg, 2000). Most if not all human
malignancies express one or more of theMyc genes (Pelen-
garis et al., 2002a). This expression is induced by oncogenes
acting upstream ofMyc (He et al., 1998; Kenney et al., 2003;
Oliver et al., 2003), suggesting that the Myc genes serve as
intermediaries through which multiple oncogenes regulate
cell growth. Tissue specificity of enhancers in theMyc genes
suggests that, in addition to a TF induced by an oncogene,
an enhancer element requires tissue-specific cooperating
factors to induce Myc transcription. A particular oncogenic
mutation that results, for example, in the induction of the
Hh pathway would be predicted to induce N-Myc expression
and cause tumors only in tissues where the presence of
these collaborating factors would allow activation of en-
hancer elements such as CM5 and CM7 (see Figures 7B
and 7C). This would explain why mutations activating the Hh
pathway are only observed in some tumor types and could
thus provide a general mechanism explaining the tumor-
type selectivity of oncogenes. In addition, because contin-
ued expression of Myc is required for tumorigenesis (Pelen-
garis et al., 2002b), these collaborating factors will also rep-
resent potential targets for chemotherapeutic drugs.
EXPERIMENTAL PROCEDURES
Constructs
Coding regions of GLI1–3 zinc-finger domains, Tcf4 lacking 30 NH2-ter-
minal amino acids, and full-length c-Ets1 were amplified by PCR usingPfu
polymerase (Stratagene) and cloned into pGEN expression vector (Tai-
pale et al., 2000) as N-terminal fusions to Renilla luciferase.
For generation of the lacZ reporter constructs, 1–2 kb genomic se-
quences carrying the predicted enhancer element were amplified by
PCR and cloned into pTKPD (Goldhamer et al., 1995), which contains
a TK minimal promoter followed by an E. coli lacZ gene with SV40 T nu-
clear localization signal. The genomic sequences included 200–250 bp
flanks (see Table S8) that were not contained in the EEL alignments.
The flanks were included because not all TF binding specificities are
known and, consequently, the EEL alignment may start too late or termi-
nate prematurely. All constructs were sequence verified.
Cell Culture and Transfections
Drosophila S2 cells were cultured in Drosophila-SFM (Invitrogen) with
10% fetal bovine serum (FBS) and antibiotics. Human 293T cells were cul-
tured in RPMI medium supplemented with 10% FBS. Drosophila proteins
were expressed in S2 cells transiently transfected with Effectene (Qiagen)
according to manufacturer’s instructions. Mammalian proteins were ex-
pressed in 293T cells transiently transfected using FuGENE 6 (Roche) es-
sentially as described (Taipale et al., 2000). Cell extracts were collected
48 hr after transfection.
TF Binding Assay and EMSA Analysis
Binding was performed in 100 ml of binding buffer (140 mM KCl, 5 mM
NaCl, 1 mM K2HPO4, 2 mM MgSO4, 20 mM HEPES [pH 7.05], 100 mM
EGTA, 1 mM ZnSO4) supplemented with 0.2% TX-100, 1% milk powder,
and 5 mg/ml poly(dI-dC) (Amersham). One picomole of biotinylated con-
sensus double-stranded DNA oligonucleotide was competed with non-
biotinylated competitor DNA in 30-fold molar excess. TF-Renilla luciferase
fusion protein lysate containing 2.5  106 relative light units was added
into the DNAmixture and incubated for 2 hr at RT. Subsequently, the mix-
ture was added onto streptavidin-coated plates (ABgene), incubated for
2 hr at RT, and washed with binding buffer, and the amount of TF bound
to the plate was measured using a luminometer (BMG FluoStar) and the
Renilla luciferase assay (Promega). Relative affinity (Kdsample/Kdconsensus)
was calculated from the light units obtained using the following equa-
tion derived from the law of mass action: [(Lscrambled/Lconsensus) 
(Lsample/Lconsensus)]/[(Lsample/Lconsensus)  1]  [(Lscrambled/Lconsensus)  1].
Oligonucleotides used are described in Supplemental Data.EMSA was performed according to manufacturer’s instructions (Pierce
LightShift Kit). Briefly, the TF-Renilla luciferase fusion protein lysate was
incubated for 1 hr with biotinylated DNA probe and nonbiotinylated com-
petitor DNA oligonucleotide (50-fold molar excess) in binding buffer sup-
plemented with 0.2% TX-100, 1%milk powder, and 25 ng/ml poly(dI-dC).
The resulting complexes were resolved in a 5% nondenaturing PAGE-gel,
transferred onto membrane, and detected using streptavidin-HRP conju-
gate and a chemiluminescent substrate.
In Silico Methods
Computational methods are described in the Supplemental Data. The
open source EEL program is available under GNU general public license
at http://www.cs.helsinki.fi/u/kpalin/EEL/.
In Situ Hybridization and Transgenic Analyses
Whole-mount in situ hybridization was performed essentially as described
(Henrique et al., 1995). Probes were generated using PCR (primers de-
scribed in Tables S3 and S4). For enhancer analysis, enhancer-mod-
ule-minimal promoter lacZ constructs were liberated from vector se-
quences, and TG embryos were produced by pronuclear injection of
FVB/N one-cell-stage embryos. LacZ staining was performed essentially
as described (Nagy et al., 2003). At least four LacZ-positive F0 embryos
were analyzed for each construct. All constructs resulted in LacZ expres-
sion in 50% or more of the TG-positive embryos (genotyping PCR primers
AAGCGGTGAAGTGCCTCTGG and GGGGAGCGTCACACTGAGGT).
To rule out ectopic expression due to differences in TG integration sites,
only consistent expression patterns are indicated (75% or more of LacZ+
embryos expressed LacZ in these tissues). Embryos were photographed
under dark-field illumination.
The genes analyzed in the in situ hybridization and TG validation (Fig-
ure 4) experiments were picked in a systematic fashion (see Tables S3,
S4, and S8) from a group of genes located close to predicted enhancers
with high TCF or GLI affinity scores conserved in human andmouse or hu-
man, mouse, and rat.
Supplemental Data
Supplemental Data include three figures, Supplemental Experimental
Procedures, Supplemental References, and nine tables and can be found
with this article online at http://www.cell.com/cgi/content/full/124/1/
47/DC1/.
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